An impact of single nucleotide polymorphisms in ABC transporter genes on achieving and maintaining molecular response in Chronic Myeloid Leukemia patients treated with nilotinib
Latest Information Update: 21 Jul 2020
At a glance
- Drugs Nilotinib (Primary)
- Indications Chronic myeloid leukaemia
- Focus Pharmacodynamics; Therapeutic Use
- 21 Jun 2020 Results evaluating the effect of 7 SNPs in 4 ABC genes on the achievement and/or loss of molecular response, presented at the 25th Congress of the European Haematology Association.
- 23 Jul 2018 New trial record
- 17 Jun 2018 Results presented at the 23rd Congress of the European Haematology Association